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PRE AND POST HSCT EVALUATION INDICATES REDUCTION OF PHYSICAL
AND FUNCTIONAL PERFORMANCE DUE TO TRANSPLANT
De Souza, C.V., Miranda, E.C.M., De Souza, C.A., Aranha, F.J.P.,
Vigorito, A.C. University of Campinas - UNICAMP, Campinas, S~ao
Paulo, Brazil
Introduction: Before, during and after hematopoietic stem cell
transplantation (HSCT) patients (pts) go throw significant physical,
psychological and psychosocial stress. This prospective study evalu-
ated physical and functional performance of pts pre and post HSCT
using a functional assessment.
Pts and Methods: From November 2008 to September 2010, 50
pts, median age 48 (18-67), 29 (58%) female, were enrolled in the
study. Data collection was performed pre and post autologous or al-
logeneic HSCT. The instruments were 2 minutes walking test
(2MWT), oxygen saturation (Sa02), heart rate (HR) and Borg Scale
(BS) before and after 2MWT for gate performance evaluation; Grip
Strength (GS) for hand strength evaluation, Schober Test (ST) for
spine mobility testing and maximum and adapted activity score
(MAS and AAS) of Human Activity Profile (HAP) questionnaire
for function role evaluation.
Results: 50 pts with hematological malignancies were evaluated pre
HSCT; 8 did not undergo HSCT; 3 died, 2 refused, 2 are in line and
1 was excluded. 42 out of 50 (84%) underwent HSCT, 21 allogeneic
and 21 autologous. 29 out of 42 (69%) pts performed both evalua-
tions; 13 pts did not perform both evaluations: 11 died prematurely
and 2 did not discharge until last analysis. Among groups who per-
formed both evaluations, we found significant lower values in the
2nd evaluation: 2MWT (p 5 0.007), GS for right and left hand (p
5 0.004 and 0.007), ST (p\ 0.0001), MAS and AAS (p\ 0.0001);
and higher values in HR (p5 0.02). Significant statistical differences
indicate decrease on aerobic conditioning at baseline and after phys-
ical stress, decline of function and gate performance, reduction of
muscle strength and spine flexibility and diminishing on function
role on daily activities post HSCT.
Conclusion:Our results suggest there were significant physical los-
ses in this population and that its intensity and specificity may guide
preventive measures and conduct a better rehabilitation program on
post HSCT period.
Support: FAPESP.242
EXECUTIVE FUNCTIONING IN PEDIATRIC STEM CELL TRANSPLANTA-
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Advances in the treatment of children undergoing stem cell trans-
plants (SCT) has led to greater rates of survival and a need for greater
understanding of cognitive late effects associated with that treat-
ment. The general clinical impression has been that heavily treated
leukemia patients who come to transplant with the burden of intra-
thecal chemotherapy to go under total body irradiation (TBI), with
or without cranial boost, in their preparative regimen may be at
a high risk of changes in their neuro-cognitive function post trans-
plant. This brief case-control investigation tested 18 children before
puberty. Eight post allogeneic bone marrow transplant recipients
(mean age10.79 years), who had received their transplant for leuke-
mia between 1995 and 2007, comprised the SCT group (See Table
1 for SCT group demographics). Ten typically developing children
(mean age11.00 years) comprised the control group of siblings (re-
gardless of age and gender) of the target group, to match as close
as possible factors such as environmental stimulation and genetic
role in intelligence and performance. All subjects were administered
the Wechsler Intelligence Scale for Children, 4th Edition and the
Wisconsin Card Sorting Task as part of a comprehensive neurocog-
nitive battery. Functional imaging was acquired for all subjects. A
behavioral task, NoGo/Go to employed to assess inhibitory func-
tioning. Results indicated no significant differences between the
SCT and control groups on performance of theNoGo/Go task. Spe-
cifically, there were no significant differences in accuracy in Nogo/
Go Hits (p 5 0.99), Nogo/Go D-prime (p 5 0.96), or Go-only
Hits (p 5 0.13). There were also no significant differences betweenthe groups with regard to response times in the Nogo/Go (p5 0.50)
or Go-only conditions (p 5 0.24). These findings indicate that the
networks that subserve executive functioning abilities, particularly
inhibitory control, are similar for children who undergo SCT, de-
spite of their treatments, and typically developing children. While
the sample size of this study is small and limits generalizability,
this study results were different than what was expected and substan-
tiates the utility of imaging technology to better understand the long
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BRONCHIOLITIS OBLITERANS SYNDROME AFTER HEMATOPOIETIC STEM
CELL TRANSPLANTATION: ANALYSIS OF SINGLE CENTER EXPERIENCE
Fujii, N., Hara, Y., Nishinohara, M., Kondo, E., Maeda, Y.,
Shinagawa, K., Tanimoto, M. Okayama University Hospital, Okayama,
Japan
Background: Bronchiolitis obliterans (BOS) after allogeneic stem
cell transplantation (allo-SCT) is a late-onset, life-threatening respi-
ratory complication that reduces patients’ quality of life. Although
some risk factors of BOS have been reported, most previous studies
were reported before 2000. Here, we retrospectively analyzed the in-
cidence of, and risk factors, for BOS among patients before 2010 to
determine whether a recent transplant procedure (e.g., cord blood or
non-myeloablative transplant) affects the incidence of BOS.
Patients and Methods: Between May 1995 and June 2010, 253 pa-
tients underwent allo-SCT for hematological malignancies at
Okayama University Hospital, and 162 who survived at least 100
days after allo-SCT (R-PBSCT, 70; UR-BMT, 57; and CBT, 35)
were evaluated in this study. Clinical diagnosis of BOS was deter-
mined using pulmonary function tests and typical changes on
high-resolution computed tomography.
Results:The incidence of BOSwas 5.5% (n5 9). Themedian age of
BOS patients was 41 years (range, 24-46) and the patient group com-
prised eight females and one male. The graft source was UR-BM in
one and R-PBSC in eight patients. No BOS was observed among
CBT recipients. Eight of nine BOS patients received a myeloablative
regimen and one BOS patient received a Flu-based non-myeloabla-
tive regimen. The median onset of BOS was 10 months (range, 3-45)
after transplant. Dry cough was the most common first symptom of
BOS. Four of nine BOS patients are still alive and the median sur-
vival after BOS was 32 months (range, 4-96). Univariate analysis re-
vealed that R-PBSCT, female gender, young age (\ 50 years),
myeloablative conditioning regimen, and extensive chronic GVHD
are risk factors for BOS.
Conclusions:Our results showed that the incidence of BOS in non-
myeloablative transplants was lower than in myeloablative trans-
plants. Although no BOS was observed among CBT recipients, the
difference was not significant compared with another graft source.244
OPTIMAL DURATION AND FREQUENCY OF IN-HOSPITAL LAY CARE-
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